Li & Fung Limited:企業の戦略・SWOT・財務情報

◆英語タイトル:Li & Fung Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4692
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:輸送・物流
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Li & Fung Limited – Strategy, SWOT and Corporate Finance Report
Summary

Li & Fung Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Li & Fung Limited (Li & Fung or ‘the company’), a member of the Fung Group, is a multinational consumer goods design, development, sourcing, and logistics company. It manages the supply chain for retailers and brands worldwide. The company provides supply chain management solutions for global brands, hypermarkets, specialty stores, department stores, catalogue-led companies, and e-commerce platforms. It deals with a range of consumer products, from soft goods such as garments and apparel to hard goods such as toys, home furnishings, sporting goods, footwear, and health and beauty products. The company offers end-to-end solutions to meet its customers’ needs through its offices and distribution centers spanning across Asia-Pacific, the Americas, Europe and Africa.. Li & Fung is headquartered in Kowloon, Hong Kong.

Scope

- Detailed information on Li & Fung Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Li & Fung Limited in the form of a SWOT analysis
- An in-depth view of the business model of Li & Fung Limited including a breakdown and examination of key business segments
- Intelligence on Li & Fung Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Li & Fung Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Li & Fung Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Li & Fung Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Li & Fung Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Li & Fung Limited: Company Overview 9
Li & Fung Limited: Overview and Key Facts 9
Li & Fung Limited: Overview 9
Li & Fung Limited: Key Facts 9
Li & Fung Limited: Key Employees 10
Li & Fung Limited: Key Employee Biographies 12
Li & Fung Limited: Major Products and Services 17
Li & Fung Limited: Company History 18
Li & Fung Limited: Management Statement 22
Li & Fung Limited: Locations and Subsidiaries 24
Li & Fung Limited: Key Competitors 25
Li & Fung Limited: Company Analysis 26
Li & Fung Limited: Business Description 26
Li & Fung Limited: SWOT Analysis 27
Li & Fung Limited: SWOT Overview 27
Li & Fung Limited: Strengths 27
Li & Fung Limited: Weaknesses 28
Li & Fung Limited: Opportunities 28
Li & Fung Limited: Threats 29
Li & Fung Limited: Corporate Financial Deals Activity 31
Li & Fung Limited: Financial Deals Overview 31
Li & Fung Limited: Top Deals 2014 – 2018YTD* 33
Li & Fung Limited: Advisors 34
Li & Fung Limited: Top Legal Advisors 34
Li & Fung Limited: Divestments 35
Li & Fung Limited: Recent Developments 36
Li & Fung Limited: News and Events Summary 36
Li & Fung Limited: Business Expansion 38
Li & Fung Limited: Contracts 39
Li & Fung Limited: Financial Deals 40
Li & Fung Limited: Financial Performance 40
Li & Fung Limited: Research & Development 41
Li & Fung Limited: Strategy and Operations 41
Appendix 43
Contact Us 43
Methodology 43
About MarketLine 44

List of Tables
Table 1: Li & Fung Limited: Key Facts
Table 2: Li & Fung Limited: Key Employees
Table 3: Li & Fung Limited: Locations and Subsidiaries
Table 4: Li & Fung Limited: Key Competitors
Table 5: Li & Fung Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Li & Fung Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Li & Fung Limited: Top Deals 2014 - 2018YTD*
Table 8: Li & Fung Limited: Legal Advisor Ranking by Value (US$m)
Table 9: Li & Fung Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 10: Li & Fung Limited: News and Events Summary
Table 11: Li & Fung Limited: Business Expansion
Table 12: Li & Fung Limited: Contracts
Table 13: Li & Fung Limited: Financial Deals
Table 14: Li & Fung Limited: Financial Performance
Table 15: Li & Fung Limited: Research & Development
Table 16: Li & Fung Limited: Strategy and Operations

List of Figures
Figure 1: Li & Fung Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Li & Fung Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Li & Fung Limited: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Li & Fung Limited:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Union Bank of India:企業のM&A・事業提携・投資動向
    Union Bank of India - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Union Bank of India Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • OncoTherapy Science Inc (4564):製薬・医療:M&Aディール及び事業提携情報
    Summary OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and d …
  • Reliance Communications Limited:企業の戦略・SWOT・財務情報
    Reliance Communications Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Communications Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bachem Holding AG (BANB):製薬・医療:M&Aディール及び事業提携情報
    Summary Bachem Holding AG (Bachem) is a technology-based biochemical company which develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem offers its products and services to the pharmaceutical and bi …
  • Daimler AG (DAI)-エネルギー分野:企業M&A・提携分析
    Summary Daimler AG (Daimler) is an automobile company that undertakes the manufacture, distribution and sales of premium passenger cars, commercial vehicles and related spare part and accessories. The company also provides services such as financing, leasing, fleet management, insurance, financial i …
  • Taiga Biotechnologies Inc-製薬・医療分野:企業M&A・提携分析
    Summary Taiga Biotechnologies Inc (Taiga Biotech) is a biopharmaceutical company that develops protein and cellular therapies. The company develops therapies for diseases including cancers and infectious diseases. Its pipeline products include programs such as stem cell therapy and target specific T …
  • TPI Triunfo Participacoes e Invest. SA (TPIS3):企業の財務・戦略的SWOT分析
    TPI Triunfo Participacoes e Invest. SA (TPIS3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Discovery Inc (DISCA):企業の財務・戦略的SWOT分析
    Discovery Inc (DISCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Tulane University:製薬・医療:M&Aディール及び事業提携情報
    Summary Tulane University (Tulane) is an educational service provider that provides biomedical courses and research programs. The university provides educational courses in the fields of architecture, business, law, liberal arts, medicine, public health and tropical medicine, science, engineering, a …
  • Komunalna poistovna, a.s. Vienna Insurance Group:企業の戦略的SWOT分析
    Komunalna poistovna, a.s. Vienna Insurance Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Spicers Ltd:企業の戦略的SWOT分析
    Spicers Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Evox Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Evox Therapeutics Ltd (Evox Therapeutics) is a biotechnology company focused on harnessing and engineering the natural delivery capabilities of exosomes, to develop novel medicines for various diseases. Its development pipeline is focused in the therapeutic areas of inflammatory, immune dise …
  • FPT Securities Joint Stock Company (FTS):企業の財務・戦略的SWOT分析
    FPT Securities Joint Stock Company (FTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Nevro Corp (NVRO):企業の財務・戦略的SWOT分析
    Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hindustan ZInc Ltd:戦略・SWOT・企業財務分析
    Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ambu AS (AMBU B):企業の財務・戦略的SWOT分析
    Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Viesgo:電力:M&Aディール及び事業提携情報
    Summary Viesgo, formerly E.ON Espana SL is an energy company that generates, distributes and markets electric power and gas. The company operates coal-fired power plants, combined cycle plants, biomass plants, and hydraulic power stations. It also provides public and private charging stations for el …
  • Mexco Energy Corp:企業の財務・戦略的SWOT分析
    Summary Mexco Energy Corp (Mexco Energy) is an oil and gas company that offers exploration, acquisition, production, and development of crude oil, natural gas, condensate liquids, and natural gas liquids. The company acquires producing and non-producing oil and gas leases from landowners and leaseho …
  • Surface Oncology Inc (SURF):製薬・医療:M&Aディール及び事業提携情報
    Summary Surface Oncology Inc (Surface Oncology) is an immuno-oncology company that develops novel antibody therapies for the treatment of cancer. The company’s lead product candidate SRF231 is a human antibody that inhibits the activity of CD47, a protein overexpressed on many types of cancer cells …
  • BASF Corp:企業のM&A・事業提携・投資動向
    BASF Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BASF Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆